EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Long‐Term Outcomes of Living Donor Liver Transplantation in Children With Alagille Syndrome: Results From Vanguard Multicenter Study of International Living Donor Liver Transplantation Group

Yusuke Yanagi iD, Sinya Okumura iD, Taiichi Wakiya iD, Yuta Hirata iD, Jiyoung Kim iD, Masaki Honda iD, Kazuya Hirukawa iD, Tonguc Utku Yilmaz iD, Takanobu Hara iD, Toru Ikegami iD, Mureo Kasahara iD

Pediatric Transplantation · 2026

DOI: 10.1111/petr.70426 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Yusuke Yanagi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan. Hauptthemen laut MEDLINE: Alagille Syndrome, Liver Transplantation, Living Donors. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Center for Child Health and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The morbidity and mortality after living donor liver transplantation (LDLT) in children with Alagille syndrome (AGS) are complex because of the multisystem involvement of the disease. Evidence on long‐term outcomes and donor selection remains limited.

Methods

This multicenter retrospective study included 49 pediatric patients with AGS who underwent LDLT between 2001 and 2020 at eight institutions in Japan, Korea, and Turkey. Clinical characteristics, transplant indications, donor selection, posttransplant growth, renal function, and complications were analyzed.

Results

The median age at LDLT was 1.1 years. Major indications for transplantation were severe growth failure (91.8%) and advanced liver disease with hepatic dysfunction. Based on donor evaluations, 11% of candidates were excluded due to genetic or anatomical concerns. The 5‐year patient and graft survival rates were 93.7% and 91.5%, respectively. LDLT before 2 years of age was associated with significantly greater catch‐up in height and weight. Long‐term renal deterioration was observed, particularly beyond 15 years after transplantation, and older age at LDLT was an independent predictor of lower long‐term estimated glomerular filtration rate. Cardiac anomalies were manageable with appropriate preoperative evaluation, whereas vasculopathies were observed after adolescence. A history of Kasai portoenterostomy did not significantly affect posttransplant outcomes.

Conclusions

LDLT provides excellent short‐ and long‐term outcomes in pediatric AGS. Timely LT may improve growth and preserve renal function before progressive multisystem complications become established. Long‐term surveillance and comprehensive donor evaluation remain essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alagille SyndromeLiver TransplantationLiving DonorsAdolescentChildChild, PreschoolFemaleHumansInfantMaleFollow-Up StudiesGraft SurvivalRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

Alagille syndromeliving donor liver transplantationlong‐term outcomemulticenter study

Autor:innen und Institutionen

  • Organ Transplantation Center, National Center for Child Health and Development, Tokyo, Japan.
  • Department of Pediatric Surgery, Kyushu University Graduate School of Medicine, Fukuoka, Japan.
  • Department of Surgery, Division of Hepato-Biliary-Pancreatic Surgery and Transplantation, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Surgery, Division of Gastroenterological, General and Transplant Surgery, Jichii Medical University, Tochigi, Japan.
  • Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea.
  • Department of Pediatric Surgery and Transplantation, Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan.

ORCID-Profile: Yusuke Yanagi, Sinya Okumura, Taiichi Wakiya, Yuta Hirata, Jiyoung Kim, Masaki Honda, Kazuya Hirukawa, Tonguc Utku Yilmaz, Takanobu Hara, Toru Ikegami, Mureo Kasahara

Förderung

  • National Center for Child Health and Development

Zitieren

APA

Yanagi, Y., Okumura, S., Wakiya, T., Hirata, Y., Kim, J., Honda, M., Hirukawa, K., Yilmaz, T. U., Hara, T., Ikegami, T., & Kasahara, M. (2026). Long‐Term Outcomes of Living Donor Liver Transplantation in Children With Alagille Syndrome: Results From Vanguard Multicenter Study of International Living Donor Liver Transplantation Group. Pediatric Transplantation. https://doi.org/10.1111/petr.70426

Vancouver

Yanagi Y, Okumura S, Wakiya T, Hirata Y, Kim J, Honda M, et al. Long‐Term Outcomes of Living Donor Liver Transplantation in Children With Alagille Syndrome: Results From Vanguard Multicenter Study of International Living Donor Liver Transplantation Group. Pediatric Transplantation. 2026. doi:10.1111/petr.70426

BibTeX
@article{Yanagi2026,
  author = {Yanagi, Yusuke and Okumura, Sinya and Wakiya, Taiichi and Hirata, Yuta and Kim, Jiyoung and Honda, Masaki and Hirukawa, Kazuya and Yilmaz, Tonguc Utku and Hara, Takanobu and Ikegami, Toru and Kasahara, Mureo},
  title = {Long‐Term Outcomes of Living Donor Liver Transplantation in Children With Alagille Syndrome: Results From Vanguard Multicenter Study of International Living Donor Liver Transplantation Group},
  journal = {Pediatric Transplantation},
  year = {2026},
  doi = {10.1111/petr.70426}
}
Kostenlos starten →